imperial innovations group p
(IVO:London Stock Exchange)
Director of Bioscience Ventures, Director Healthcare Ventures, and Member of Investment Committee, Imperial Innovations Group plc
|Age||Total Calculated Compensation||This person is connected to 2 board members in 2 different organizations across 5 different industries.|
See Board Relationships
Mr. Simon Kerr served as the Commercial Director of Cenes Pharmaceuticals Plc until its acquisition by Paion AG in June 2008. Mr. Kerr served as the Chief Operating Officer of Cambridge Drug Discovery Holdings Ltd. Mr. Kerr joined CeNeS Pharmaceuticals Plc in November 2003. He founded Cambridge Genetics (CGL) which merged with Cambridge Drug Discovery in December 1999. Prior to CGL, Mr. Kerr has held a number of commercial positions with Gemini Genomics, Scotia Pharmaceuticals, ...
52 Princes GatePhone: 44 20 7581 4949
London, Greater London SW7 2PG
Fax: 44 20 7594 6584
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Thomas H. McLain M.B.A||Chief Executive Officer and President|
|Yves Fradet M.D., F.R.C.S.||Co-Founder, Chairman, Chief Executive Officer, President and Chief Medical Officer|
|Kevin Kowbel||Chairman and Interim Chief Executive Officer|
Health Discovery Corporation
|Christopher J. Moreau||Chief Executive Officer, President and Non Independent Director|
|Jan Groen Ph.D.||Chief Executive Officer and Executive Director|
|€462.0K||Compensation as of Fiscal Year --.|
Post a JobJobs
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25
- Moberly, MO | Walmart MilitaryPosted: Nov 11
- Orlando, FL | Orlando HealthPosted: Dec 04